Shares of Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) have earned an average rating of “Buy” from the four brokerages that are covering the stock, Marketbeat reports. Four analysts have rated the stock with a buy rating. The average 12 month target price among brokerages that have covered the stock in the last year […]
Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Get Free Report) has received an average rating of “Buy” from the four brokerages that are currently covering the firm, Marketbeat Ratings reports. Four analysts have rated the stock with a buy rating. The average 1-year target price among brokerages that have issued a report on the stock in the […]
Adaptimmune Therapeutics plc (NASDAQ:ADAP – Get Free Report) gapped up before the market opened on Tuesday . The stock had previously closed at $1.01, but opened at $1.04. Adaptimmune Therapeutics shares last traded at $1.08, with a volume of 119,471 shares trading hands. Wall Street Analysts Forecast Growth Separately, StockNews.com assumed coverage on shares of […]
Twin Focus Capital Partners LLC reduced its holdings in NVIDIA Co. (NASDAQ:NVDA – Free Report) by 79.7% during the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,469 shares of the computer hardware maker’s stock after selling 5,753 shares during the quarter. […]
SPDR S&P Biotech ETF (NYSEARCA:XBI) Shares Acquired by MBB Public Markets I LLC themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.